The Thalidomide Survivors Compensation Act of 2025 is designed to provide financial support to individuals in the United States who were adversely affected by the drug thalidomide, which caused severe birth defects during the 1950s and 1960s. The Act aims to ensure that these survivors can maintain their dignity and independence by addressing their ongoing medical and financial needs. Central to the Act is the establishment of a Thalidomide Survivors Compensation Program, which will be created within one year of the law's enactment.